TNFRSF19 exhibits tissue-specific expression, with aberrantly elevated levels reported in various invasive cancers including colorectal cancer, lung cancer, melanoma, and GBM [[26], [27], [28]]. This evidence concerns the gene TNFRSF19 and glioblastoma.